The Clinician-Administered Post-Traumatic Stress Disorder Scale is a structured interview used to assess Post-Traumatic Stress Disorder (PTSD) symptoms and determine whether someone meets the diagnostic criteria for PTSD.
The current version is the Clinician-Administered PTSD Scale for the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders, commonly called the CAPS-5.
Developed by the U.S. Department of Veterans Affairs' National Center for PTSD, the CAPS-5 is widely regarded as a leading assessment tool for diagnosing PTSD and measuring changes in symptoms.
Unlike a questionnaire that someone completes independently, the CAPS-5 is administered by a trained interviewer who asks standardized questions and evaluates the frequency and intensity of symptoms.
Researchers frequently use the assessment in clinical trials, including studies investigating Eye Movement Desensitization and Reprocessing (EMDR) therapy.
It helps researchers determine whether participants meet PTSD diagnostic criteria before treatment and whether their symptoms change afterward.
What Is the Purpose of the CAPS-5?
The CAPS-5 provides a consistent method for assessing PTSD symptoms.
PTSD can involve several different experiences, including unwanted memories, avoidance of reminders, changes in mood, and increased alertness.
Not everyone experiences these symptoms in the same way.
Some people notice frequent unwanted memories, while others may be more affected by sleep difficulties, avoidance, or negative beliefs associated with an experience.
The CAPS-5 allows trained assessors to examine these differences using a structured interview.
Its main purposes include:
Determining whether someone meets the diagnostic criteria for PTSD.
Assessing the severity of individual PTSD symptoms.
Measuring changes in symptoms during or after treatment.
Evaluating whether PTSD diagnostic criteria are still met at follow-up.
Providing a standardized outcome measure for clinical research.
The assessment is not a treatment itself. It is a tool for understanding and measuring trauma-related symptoms.
How Was the Clinician-Administered PTSD Scale Developed?
The original Clinician-Administered PTSD Scale was developed to provide a standardized way of assessing PTSD.
As diagnostic criteria changed, the assessment was revised to reflect updated definitions of the condition.
The CAPS-5 was developed to correspond with the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), published by the American Psychiatric Association.
The revised assessment was designed to evaluate the updated PTSD symptom categories while preserving the structured approach of earlier versions.
A 2018 study by Weathers and colleagues, published in Psychological Assessment, examined the reliability and validity of the CAPS-5.
The researchers evaluated the assessment using two samples of military veterans, involving 165 and 207 participants.
The findings showed strong agreement between trained interviewers and good consistency when the assessment was repeated.
The study also found that CAPS-5 symptom scores corresponded well with other established PTSD assessments.
These findings supported its use as a reliable clinical and research instrument.
However, reliability does not mean that every assessment produces a perfectly precise result. The quality of the interview and the training of the assessor remain important.
What Symptoms Does the CAPS-5 Measure?
The CAPS-5 evaluates 20 PTSD symptoms organized into four main categories.
These categories reflect the DSM-5 diagnostic framework.
| PTSD symptom category | What the assessment examines |
|---|---|
| Intrusion symptoms | Unwanted memories, distressing dreams, and other reactions connected to reminders of an event |
| Avoidance | Efforts to avoid memories, thoughts, feelings, or external reminders |
| Changes in thoughts and mood | Negative beliefs, guilt, emotional changes, and reduced interest in activities |
| Changes in arousal and reactivity | Increased watchfulness, startle responses, sleep difficulties, and concentration problems |
Intrusion symptoms
Intrusion refers to unwanted experiences connected to a traumatic event.
These may include memories that come to mind unexpectedly, distressing dreams, or emotional reactions when encountering reminders.
The CAPS-5 examines how frequently these experiences occur and how strongly they affect the person.
Avoidance symptoms
Avoidance involves trying not to think about an event or avoiding situations associated with it.
For example, someone may avoid a particular location because it reminds them of a difficult experience.
The interview examines both avoidance of internal reminders, such as thoughts and feelings, and avoidance of external reminders.
Changes in thoughts and mood
PTSD can also involve changes in how someone thinks or feels about themselves, other people, or the world.
The CAPS-5 assesses experiences such as persistent negative beliefs, guilt, reduced interest in activities, and difficulty experiencing positive emotions.
Changes in arousal and reactivity
This category includes symptoms associated with heightened alertness or changes in everyday reactions.
Examples include sleep difficulties, irritability, concentration problems, and being unusually watchful.
By examining these categories separately, the CAPS-5 helps provide a more detailed picture of PTSD symptoms than a single general question about distress.
How Is the CAPS-5 Interview Conducted?
The CAPS-5 is administered by a trained clinician, clinical researcher, or another appropriately trained interviewer.
A complete interview generally takes 45 to 60 minutes.
The interviewer follows a structured set of questions while allowing clarification when necessary.
1. Identifying the relevant traumatic event
The assessment begins by establishing the traumatic event or experience that will serve as the basis for the symptom questions.
Researchers sometimes call this the index traumatic event.
This helps the interviewer determine whether the reported symptoms are connected to an experience that meets the relevant PTSD diagnostic criteria.
The Life Events Checklist for DSM-5 may also be used to help identify potentially relevant experiences.
2. Asking about symptoms
The interviewer asks questions about each PTSD symptom.
For example, they may explore whether unwanted memories occur, how frequently they arise, and how much they affect the person's daily experience.
The questions follow a standardized format so that different assessors examine the same symptom areas.
3. Clarifying frequency and intensity
The interviewer gathers information about how often a symptom occurs and how strongly it is experienced.
These two aspects are considered together when assigning a severity rating.
4. Assessing everyday functioning
The interview also examines whether symptoms affect relationships, work, social activities, or other areas of daily life.
This is important because a PTSD diagnosis involves more than simply recognizing that certain symptoms are present.
5. Recording and interpreting the results
The interviewer assigns ratings and evaluates whether the full diagnostic criteria are met.
The results can also provide a starting point for measuring future changes.
How Are CAPS-5 Symptoms Scored?
Each of the 20 PTSD symptoms receives a severity rating from 0 to 4.
The interviewer considers both symptom frequency and intensity when assigning the score.
| Score | Severity rating |
|---|---|
| 0 | Absent |
| 1 | Mild or below the diagnostic threshold |
| 2 | Moderate and meets the symptom threshold |
| 3 | Markedly elevated |
| 4 | Extreme |
For example, an assessor may consider how often someone experiences unwanted memories and how much those memories affect them.
A symptom that occurs infrequently and causes little disturbance may receive a lower rating.
A symptom that occurs more frequently and has a greater impact may receive a higher rating.
The CAPS-5 uses detailed scoring instructions rather than leaving the decision entirely to the interviewer's personal judgment.
How is the total score calculated?
The 20 individual symptom ratings are added together.
This produces a total PTSD symptom severity score ranging from 0 to 80.
Higher scores indicate greater overall symptom severity.
Researchers may also calculate separate scores for the four symptom categories.
Importantly, the total score alone does not determine whether someone has PTSD.
The interviewer must also consider whether the required diagnostic criteria are met.
How Does the CAPS-5 Determine a PTSD Diagnosis?
The CAPS-5 evaluates whether the person's experiences meet the DSM-5 diagnostic requirements.
These include exposure to a qualifying traumatic event, the presence of specific symptom patterns, symptom duration, and effects on daily functioning.
The diagnostic criteria require:
At least one intrusion symptom.
At least one avoidance symptom.
At least two symptoms involving changes in thoughts and mood.
At least two symptoms involving changes in arousal and reactivity.
Symptoms generally need to have been present for more than one month and be associated with clinically significant distress or difficulty functioning.
The assessment also considers whether symptoms are better explained by another cause.
A rating of 2 or higher generally indicates that an individual symptom meets the clinical threshold.
However, the diagnostic decision depends on the overall pattern of symptoms and the full criteria, not simply the number of points accumulated.
This is why two people with similar total scores may not necessarily receive the same diagnostic conclusion.
What Are the Different Versions of the CAPS-5?
The CAPS-5 has different versions corresponding to the period being assessed.
| Version | Main purpose |
|---|---|
| Past-month version | Evaluates current PTSD symptoms and diagnostic status |
| Past-week version | Measures PTSD symptoms over the previous week |
| Worst-month or lifetime version | Evaluates PTSD symptoms during the person's most affected period |
Past-month assessment
The past-month version is used when determining whether someone currently meets PTSD diagnostic criteria.
It examines symptoms experienced during the preceding month.
Past-week assessment
The past-week version focuses on symptoms occurring over the previous seven days.
Researchers may use it when they want to monitor shorter-term changes during treatment.
However, the past-week version is intended for symptom assessment rather than establishing current PTSD diagnostic status.
Lifetime assessment
The lifetime version examines the period when the person's PTSD symptoms were most pronounced.
It can help assess whether someone met diagnostic criteria at an earlier point in life.
Using the appropriate version matters because findings may differ depending on the assessment period.
How Is the CAPS-5 Used in EMDR Research?
The CAPS-5 is frequently used in research investigating treatments for PTSD, including EMDR.
EMDR is a structured psychotherapy involving attention to distressing memories while using bilateral stimulation, such as guided eye movements, alternating sounds, or tapping.
Researchers need reliable ways to determine whether participants' symptoms change during treatment.
The CAPS-5 provides a standardized method for making these comparisons.
Before treatment
Researchers may use the CAPS-5 to determine whether participants meet PTSD diagnostic criteria.
They also establish an initial symptom severity score.
This provides a starting point for comparing later assessments.
After treatment
Researchers may administer the CAPS-5 again after participants complete a course of EMDR.
The new scores can be compared with the initial scores to determine whether symptom severity has changed.
During follow-up
Some studies repeat the assessment several weeks or months after treatment.
This helps researchers investigate whether the improvements observed at the end of treatment are maintained.
By using the same assessment approach across different time points, researchers can evaluate symptom changes more consistently.
What Is an Example of the CAPS-5 Being Used in an EMDR Study?
A 2024 randomized clinical trial by Matthijssen, Brouwers, and de Jongh, published in Frontiers in Psychiatry, provides an example.
The study compared EMDR with Visual Schema Displacement Therapy and a waiting-list control condition.
Visual Schema Displacement Therapy is another psychological intervention designed to address distress associated with unwanted memories.
The researchers used the Dutch version of the CAPS-5 to assess PTSD symptoms and diagnostic status.
How was the assessment used?
Participants completed CAPS-5 assessments before treatment.
The researchers then repeated the interviews after treatment and during follow-up assessments.
Follow-up evaluations were conducted four and twelve weeks after the treatment phase.
This allowed the researchers to examine whether participants' PTSD symptoms changed and whether they continued to meet diagnostic criteria.
What did the study find?
Both active treatment groups showed reductions in PTSD symptoms.
The researchers did not find a clear difference in PTSD symptom reduction between EMDR and Visual Schema Displacement Therapy.
The study also found that both active treatments performed better than the waiting-list condition on PTSD symptom outcomes.
These findings illustrate how the CAPS-5 can be used to compare changes across different treatment conditions.
However, the results apply to the treatments and participants examined in that particular trial.
They do not mean that every person receiving EMDR will experience the same degree of improvement.
How Do Researchers Interpret Changes in CAPS-5 Scores?
Researchers can compare CAPS-5 scores collected at different assessment points.
For example, imagine a participant begins treatment with a total score of 42 and receives a score of 27 afterward.
That represents a reduction of 15 points.
The example is hypothetical, but it illustrates how symptom changes can be measured.
A lower score indicates that the interviewer rated the participant's overall PTSD symptom severity as lower at the later assessment.
What counts as meaningful improvement?
There is no single score change that can describe improvement perfectly for every person or research setting.
The U.S. Department of Veterans Affairs' National Center for PTSD notes that a reduction of approximately 10 points has been suggested as an indicator of treatment response.
Research by Marx and colleagues, published in Psychological Assessment in 2022, examined reliable and clinically significant changes in CAPS-5 scores among male military veterans.
The researchers found that reductions of approximately 12 to 13 points represented reliable change in the two clinical trial samples they examined.
Reliable change means that the reduction was large enough to be unlikely to reflect ordinary measurement variation alone.
These findings provide useful guidance, but the thresholds may not apply identically to every population.
Researchers therefore consider the score change alongside diagnostic status, daily functioning, and the broader study findings.
What Is the Difference Between Symptom Improvement and PTSD Remission?
Symptom improvement and remission are related but different outcomes.
Symptom improvement
Improvement means that PTSD symptoms have decreased in severity.
For example, someone may report fewer unwanted memories, less avoidance, or improved sleep while still experiencing some symptoms.
A lower CAPS-5 total score can help demonstrate this change.
Loss of PTSD diagnostic status
A person may no longer meet the full diagnostic criteria for PTSD after treatment.
This can occur even if some symptoms remain.
Remission
Remission generally refers to a state in which PTSD symptoms have decreased sufficiently to meet the study's definition of recovery or minimal remaining symptoms.
Researchers may use different criteria to define remission.
For this reason, a study reporting that participants no longer met PTSD diagnostic criteria is not necessarily reporting the same outcome as a study using a stricter remission threshold.
Understanding these distinctions helps readers interpret treatment findings accurately.
How Is the CAPS-5 Different From the PTSD Checklist?
Another commonly used assessment is the PTSD Checklist for DSM-5 (PCL-5).
Both instruments assess the 20 PTSD symptoms described in the DSM-5.
However, they collect information differently.
| Feature | CAPS-5 | PCL-5 |
|---|---|---|
| Assessment method | Structured interview | Self-report questionnaire |
| Who completes it | A trained interviewer rates the symptoms | The individual reports their own symptoms |
| Number of items | 30 interview items, including 20 PTSD symptoms | 20 symptom questions |
| Typical duration | 45–60 minutes | 5–10 minutes |
| Main uses | Diagnosis, symptom severity, and treatment evaluation | Screening, symptom monitoring, and provisional diagnosis |
| Symptom score range | 0–80 | 0–80 |
CAPS-5
The CAPS-5 allows the interviewer to ask follow-up questions and clarify how frequently and intensely symptoms occur.
This structured approach supports detailed diagnostic assessment.
PCL-5
The PCL-5 asks individuals to rate how much they have been bothered by particular symptoms.
It is shorter and can be useful when researchers want to collect symptom information repeatedly.
The PCL-5 can support screening and provide a provisional indication of PTSD, while the CAPS-5 is widely regarded as a leading standard for establishing a diagnosis.
Researchers sometimes use both assessments in the same study.
This allows them to compare clinician-rated symptoms with participants' own reports.
Is the CAPS-5 the Same as an EMDR Target Memory Assessment?
No. The CAPS-5 and the target memory assessment used during EMDR have different purposes.
The CAPS-5 evaluates PTSD symptoms and diagnostic status.
During the interview, the assessor identifies a relevant traumatic event and asks how symptoms relate to that experience.
The goal is to understand the person's PTSD symptom pattern.
The EMDR target assessment focuses on a memory selected for processing.
During EMDR, a target memory may be examined in terms of its associated image, negative belief, preferred positive belief, emotions, and physical sensations.
EMDR also uses measures such as the Subjective Units of Disturbance scale, which rates how upsetting a memory feels in the present moment.
These procedures are not interchangeable.
A CAPS-5 assessment can establish information about PTSD symptoms before treatment, while the EMDR assessment helps organize the processing of a particular memory.
The memory identified during a CAPS-5 interview does not automatically have to be the first memory selected for EMDR processing.
Can the CAPS-5 Be Used for Children and Adolescents?
A related version of the assessment is available for younger people.
It is called the Clinician-Administered PTSD Scale for DSM-5 — Child/Adolescent Version (CAPS-CA-5).
The assessment is designed for children and adolescents aged seven and older.
Like the adult CAPS-5, it uses a structured interview to examine PTSD symptoms.
However, the wording and assessment procedures are adapted for younger age groups.
This distinction is important because children's descriptions and experiences of trauma-related symptoms may differ from those of adults.
Using an age-appropriate assessment helps researchers evaluate symptoms in a way that is more suitable for the population being studied.
What Are the Strengths of the CAPS-5?
The CAPS-5 has several characteristics that make it useful in clinical research.
Standardized assessment
The interview follows established questions and scoring procedures.
This helps researchers assess participants consistently.
Detailed symptom information
The assessment examines individual symptoms rather than relying only on a general description of distress.
Clinician-rated severity
A trained interviewer evaluates symptom frequency and intensity together.
This provides a different perspective from self-report questionnaires.
Diagnostic information
The CAPS-5 can evaluate whether participants meet PTSD diagnostic criteria, not simply whether they report some trauma-related symptoms.
Repeated measurement
Researchers can administer the assessment at different points to investigate treatment progress.
Established reliability and validity
Published studies have examined whether CAPS-5 ratings are consistent and whether the assessment measures the intended PTSD symptoms.
These characteristics explain why the CAPS-5 is frequently used in trials involving EMDR and other trauma-focused treatments.
What Are the Limitations of the CAPS-5?
Although the CAPS-5 is a well-established assessment, it also has limitations.
It takes more time than a self-report questionnaire
A full interview generally requires 45 to 60 minutes.
This can make repeated assessments more resource-intensive in larger studies.
It requires trained interviewers
Accurate administration depends on understanding the questions, scoring rules, and diagnostic criteria.
Researchers often provide training to improve consistency between assessors.
Ratings still involve professional judgment
Although the interview uses detailed instructions, some interpretation is involved when combining symptom frequency and intensity.
Different assessors may occasionally assign different ratings.
It focuses specifically on PTSD
The CAPS-5 is designed to evaluate PTSD symptoms.
It does not provide a complete assessment of every aspect of psychological health, including all anxiety, depressive, grief-related, or other concerns.
It reflects a particular assessment period
A score describes symptoms during the time frame being examined.
It does not necessarily represent how someone feels at every moment or across their entire life.
These limitations do not make the assessment unreliable. They help explain why researchers consider interview quality, study design, and other outcome measures when interpreting results.
Why Is the CAPS-5 Important for Understanding EMDR Research?
When reading an EMDR study, it is useful to know how researchers measured treatment outcomes.
A study may report that participants experienced fewer PTSD symptoms, but that statement is more informative when the assessment method is clearly described.
If researchers used the CAPS-5, readers know that PTSD symptoms were evaluated through a structured clinical interview.
Researchers can also report whether participants continued to meet diagnostic criteria after treatment.
This provides different information from a satisfaction survey or a questionnaire asking people whether they believe their symptoms improved.
However, using the CAPS-5 does not automatically prove that a treatment caused the observed changes.
The study design still matters.
For example, a randomized controlled trial comparing EMDR with another treatment can provide stronger evidence about relative treatment effects than a study measuring only one group before and after treatment.
The CAPS-5 strengthens the consistency of outcome measurement, while the broader research design determines what conclusions can be drawn about treatment effectiveness.
What Is the Main Takeaway?
The Clinician-Administered PTSD Scale for DSM-5 is a structured interview used to diagnose PTSD and measure the severity of trauma-related symptoms.
It assesses 20 PTSD symptoms across four categories and uses additional questions to examine symptom duration, daily functioning, and other diagnostic information.
Each symptom receives a rating from 0 to 4, producing a total severity score ranging from 0 to 80.
Researchers commonly use the CAPS-5 before and after treatment to investigate whether symptoms have changed.
In EMDR research, it provides a standardized method for evaluating PTSD outcomes and comparing results across treatment groups.
The most important distinction is that the CAPS-5 measures PTSD symptoms and diagnostic status, while EMDR uses separate procedures to select and assess memories for processing.
Understanding how the CAPS-5 works can help readers interpret EMDR studies more accurately and distinguish between clinician-rated clinical outcomes, self-reported changes, and treatment effectiveness.
References
U.S. Department of Veterans Affairs, National Center for PTSD. Clinician-Administered PTSD Scale for DSM-5 (CAPS-5).
https://www.ptsd.va.gov/professional/assessment/adult-int/caps.asp
Weathers, F. W., Bovin, M. J., Lee, D. J., et al. (2018). The Clinician-Administered PTSD Scale for DSM-5 (CAPS-5): Development and initial psychometric evaluation in military veterans. Psychological Assessment, 30(3), 383–395.
https://doi.org/10.1037/pas0000486
Matthijssen, S. J. M. A., Brouwers, T. C., & de Jongh, A. (2024). Visual Schema Displacement Therapy versus Eye Movement Desensitization and Reprocessing therapy versus waitlist in the treatment of post-traumatic stress disorder: Results of a randomized clinical trial. Frontiers in Psychiatry, 15, 1377108.
https://doi.org/10.3389/fpsyt.2024.1377108
Marx, B. P., Lee, D. J., Norman, S. B., et al. (2022). Reliable and clinically significant change in the Clinician-Administered PTSD Scale for DSM-5 and PTSD Checklist for DSM-5 among male veterans. Psychological Assessment, 34(2), 197–203.
https://doi.org/10.1037/pas0001098
U.S. Department of Veterans Affairs, National Center for PTSD. PTSD Checklist for DSM-5 (PCL-5).
https://www.ptsd.va.gov/professional/assessment/adult-sr/ptsd-checklist.asp
International Society for Traumatic Stress Studies. Clinician Administered PTSD Scale.
https://istss.org/clinical-resources/adult-trauma-assessments/clinician-administered-ptsd-scale/
